newsfilter
← Latest News
ACCESS Newswire·

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

BOULDER, CO / ACCESSWIRE / September 19, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid